Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices, 32571-32572 [2015-14057]

Download as PDF 32571 Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices tool for monitoring of the P&As, including the public input requirement. Furthermore, it will provide an overview of program priorities, and permit AIDD to track accomplishments against goals, permitting the formulation of technical assistance and compliance with the Developmental Disabilities Assistance and Bill of Rights Act of 2000. Submit written comments on the collection of information by August 10, 2015. ADDRESSES: Submit written comments on the collection of information by email to: Valerie.Bond@aoa.hhs.gov. FOR FURTHER INFORMATION CONTACT: Valerie Bond, Administration on Community Living, Administration on Intellectual and Developmental Disabilities, Office of Program Support, DATES: One Massachusetts Avenue NW., Room 4302, Washington, DC 20201, 202–690– 5841. SUPPLEMENTARY INFORMATION: In compliance with the requirements of section 506 (c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration on Community Living is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to: Valerie Bond, Administration on Community Living, Administration on Intellectual and Developmental Disabilities, Office of Program, One Massachusetts Avenue, NW., Room 4302, Washington, DC 20201. The Department specifically requests comments on: (a) Whether the proposed Collection of information is necessary for the proper performance of the function of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden information to be collected; and (e) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection technique comments and or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Respondents: 57 Protection and Advocacy Systems ANNUAL BURDEN ESTIMATES Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours State Developmental Disabilities Council 5-Year State Plan .......................... 57 1 44 2,508 Estimated Total Annual Burden Hours: 2,508. Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. Dated: June 3, 2015. Kathy Greenlee, Administrator and Assistant Secretary for Aging. [FR Doc. 2015–14050 Filed 6–8–15; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0373] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Risk and Benefit Perception Scale Development AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Risk and Benefit Perception Scale Development’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:12 Jun 08, 2015 Jkt 235001 On November 28, 2015, the Agency submitted a proposed collection of information entitled ‘‘Risk and Benefit Perception Scale Development’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0784. The approval expires on May 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: June 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–14027 Filed 6–8–15; 8:45 am] BILLING CODE 4164–01–P PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0672] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ‘‘Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: On April 23, 2015, the Agency submitted a proposed collection of information entitled, ‘‘Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices’’ to OMB for review and clearance under 44 U.S.C. 3507. An SUMMARY: E:\FR\FM\09JNN1.SGM 09JNN1 32572 Federal Register / Vol. 80, No. 110 / Tuesday, June 9, 2015 / Notices Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0577. The approval expires on May 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: June 3, 2015. Leslie Kux, Associate Commissioner for Policy. and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0788. The approval expires on May 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: June 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–14056 Filed 6–8–15; 8:45 am] [FR Doc. 2015–14057 Filed 6–8–15; 8:45 am] BILLING CODE 4164–01–P BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Food and Drug Administration [Document Identifier: HHS–OS–0990–New– 30D] [Docket No. FDA–2014–N–2294] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ‘‘Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUMMARY: On April 15, 2015, the Agency submitted a proposed collection of information entitled, ‘‘Evaluation of the Food and Drug Administration’s ‘Fresh Empire’ Multicultural Youth Tobacco Prevention Campaign’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, tkelley on DSK3SPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:12 Jun 08, 2015 Jkt 235001 Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, has submitted an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB) for review and approval. The ICR is for a new collection. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public on this ICR during the review and approval period. DATES: Comments on the ICR must be received on or before July 9, 2015. ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Information Collection Clearance staff, Information.CollectionClearance@ hhs.gov or (202) 690–6162. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the Information Collection Request Title and document identifier HHS–OS– 0990–New–30D for reference. SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Information Collection Request Title: Midwest HIV Prevention and Pregnancy Planning Initiative (MHPPPI). Abstract: HHS Office of the Assistant Secretary for Health (OASH)/Office of Women’s Health (OWH) is seeking an approval on a new information collection request by the Office of Management and Budget (OMB), the program office initiatives on the evaluation of the MHPPPI will be conducted by the AIDS Foundation of Chicago’s (AFC) internal Research, Evaluation and Data Services (REDS) department, which specializes in documenting, evaluating and analyzing the process, impact and outcomes of health programs. The evaluation framework for MHPPPI includes process monitoring, impact evaluation, outcome evaluation and dissemination. The impact evaluation will be informed by an initial climate survey of a sample of medical providers within the Midwest to develop a conservative baseline estimate of the counterfactual model. The counterfactual model will postulate what would have happened without the intervention. The impact evaluation will also document and analyze the degree to which services are integrated in medical settings based on change agent surveys administered through participating trainees. The outcome evaluation will assess changes that occurred in each domain as a result of the intervention, including knowledge, attitudes and behaviors related to the specific training content. The overall evaluation goal is to assess whether or not MHPPPI: (1) Increased the knowledge of providers, (2) Facilitated the integration of pregnancy planning into the care of HIV-positive women/women with HIVpositive partners, and (3) Increased access to innovative HIV prevention options in communities with high HIV prevalence. Likely Respondents: Æ HIV Primary Care Providers D Anyone who provides primary HIV care to persons of reproductive age (15– 49) Æ Reproductive Health Care Providers D Anyone who provides reproductive health care to HIV+ persons or HIV¥ persons with HIV+ partners. Æ HIV-positive and HIV-negative women receiving reproductive health care E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 80, Number 110 (Tuesday, June 9, 2015)]
[Notices]
[Pages 32571-32572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14057]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0672]

Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Prominent and Conspicuous Mark of
Manufacturers on Single-Use Devices

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled, ``Prominent and Conspicuous Mark of
Manufacturers on Single-Use Devices'' has been approved by the Office
of Management and Budget (OMB) under the Paperwork Reduction Act of
1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On April 23, 2015, the Agency submitted a
proposed collection of information entitled, ``Prominent and
Conspicuous Mark of Manufacturers on Single-Use Devices'' to OMB for
review and clearance under 44 U.S.C. 3507. An

[[Page 32572]]

Agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information unless it displays a currently
valid OMB control number. OMB has now approved the information
collection and has assigned OMB control number 0910-0577. The approval
expires on May 31, 2018. A copy of the supporting statement for this
information collection is available on the Internet at https://www.reginfo.gov/public/do/PRAMain.

Dated: June 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-14057 Filed 6-8-15; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.